MedPath
NMPA Approval

Levosimendan Injection

国药准字H20243485

April 11, 2024

Drug Information

左西孟旦注射液

注射剂

5ml∶12.5mg

化学药品

April 11, 2024

Company Information

Applicant Company

成都市温江区成都海峡两岸科技产业开发园区海科路西段459号

Manufacturing Company

成都市温江区成都海峡两岸科技产业开发园区海科路西段459号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

左西孟旦注射液 - NMPA 批准文号 | MedPath